...
机译:结构和镇痛活性为13-(N-芳基(N,N-二乙基)氨基羰基)-9-甲基-11-硫代氧基-8-氧气-10,12-二氮杂环[7.3.1.0(2,7)] Trideca- 2,4,6-三烯及其10-苯基衍生物
Perm State Pharmaceut Acad Minist Hlth Russian Federat 2 Polevaya St Perm 614990 Russia;
Perm State Pharmaceut Acad Minist Hlth Russian Federat 2 Polevaya St Perm 614990 Russia;
Perm State Pharmaceut Acad Minist Hlth Russian Federat 2 Polevaya St Perm 614990 Russia;
Perm State Pharmaceut Acad Minist Hlth Russian Federat 2 Polevaya St Perm 614990 Russia;
Perm State Natl Res Univ 15 Bukireva St Perm 614000 Russia;
three-component reaction; N-aryl(N; N-diethyl)amides of acetoacetic acid; salicylaldehyde; thiourea; phenylthiourea; sodium bisulfate; 9-methyl-11-thioxo-8-oxa-10; 12-diazatricyclo7; 3; 1; 02; 7 trideca-2; 4; 6-trienes; x-ray crystal structure analysis; analgesic activity; acute toxicity;
机译:结构和镇痛活性为13-(N-芳基(N,N-二乙基)氨基羰基)-9-甲基-11-硫代氧基-8-氧气-10,12-二氮杂环[7.3.1.0(2,7)] Trideca- 2,4,6-三烯及其10-苯基衍生物
机译:N-芳基和N,N-二乙基-9-甲基-11-亚磺酰基-8-oxa-10,12-二氮杂三环[7.3.1.0(2,7)] trideca-2,4,6-triene-的合成13-羧酰胺
机译:1-(4-溴-9-甲基-11-thioxo-8-oxa-10,12-二氮杂三环[7.3.1.0〜(2.7)] trideca-2,4,6-trien-13-yl的晶体结构乙酮
机译:N-芳基衍生物作为胆碱酯酶抑制剂的定量构效关系(QSAR)模型
机译:10-羟基-4-甲氧基-5,9-二甲基 - 三环的合成和晶体结构3.3.1.02,7 Trideca-2,4,6-三烯-13-1